SciTechDaily – Science, Space and Technology News 2022
Science, Space and Technology News 2022
Science, Space and Technology News 2022
Aventa Genomics, a joint venture of Arima Genomics and Protean BioDiagnostics, launched the Aventa FusionPlus test for patients with solid cancers.
Aventa Genomics has launched its next-generation sequencing (NGS) test, Aventa FusionPlus, to identify gene fusions and translocations.
Health & Fitness · 2023
Cannabis is widely used by patients with cancer to help with cancer symptoms and treatment side effects. Though cannabis has immunomodulatory effects, and its consumption…
/PRNewswire-PRWeb/ — Protean BioDiagnostics is proud to announce its partnership with Travera. As one of Travera’s first Center of Excellence, the partnership…
Protean’s new partnership with Travera will bring expanded treatment options to advanced carcinoma patients and their physicians.
ChromaCode has entered into a partnership with Protean BioDiagnostic for the launch of a non-small cell lung cancer (NSCLC) assay in the US.
Protean is excited to partner with ChromaCode, Inc., to bring innovative cancer diagnostic technologies to oncologists and patients!
/PRNewswire/ — ChromaCode, Inc., a genomics multiplexing platform company developing accessible and affordable solutions for laboratories, patients, and…
Cancer Informant is a podcast made to inform cancer patients and their loved ones about their options for cancer testing and treatment. Dr. Tony Magliocco…